Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Charming Medical (MCTA) Competitors

Charming Medical logo
$29.36 +1.86 (+6.76%)
As of 03:30 PM Eastern
Compare

MCTA vs. ADUS, SGRY, VRDN, PGNY, and SNDA

Should you buy Charming Medical stock or one of its competitors? MarketBeat compares Charming Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Charming Medical include Addus HomeCare (ADUS), Surgery Partners (SGRY), Viridian Therapeutics (VRDN), Progyny (PGNY), and Sonida Senior Living (SNDA). These companies are all part of the "healthcare" industry.

How does Charming Medical compare to Addus HomeCare?

Charming Medical (NASDAQ:MCTA) and Addus HomeCare (NASDAQ:ADUS) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

In the previous week, Addus HomeCare had 13 more articles in the media than Charming Medical. MarketBeat recorded 16 mentions for Addus HomeCare and 3 mentions for Charming Medical. Addus HomeCare's average media sentiment score of 0.53 beat Charming Medical's score of 0.11 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charming Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Addus HomeCare
7 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare has higher revenue and earnings than Charming Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charming MedicalN/AN/AN/AN/AN/A
Addus HomeCare$1.42B1.22$95.91M$5.4117.13

Addus HomeCare has a net margin of 6.89% compared to Charming Medical's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Charming Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Charming MedicalN/A N/A N/A
Addus HomeCare 6.89%9.80%7.34%

Addus HomeCare has a consensus price target of $131.22, indicating a potential upside of 41.63%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.73

95.4% of Addus HomeCare shares are held by institutional investors. 4.5% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Addus HomeCare beats Charming Medical on 12 of the 12 factors compared between the two stocks.

How does Charming Medical compare to Surgery Partners?

Charming Medical (NASDAQ:MCTA) and Surgery Partners (NASDAQ:SGRY) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

Charming Medical has a net margin of 0.00% compared to Surgery Partners' net margin of -2.28%. Surgery Partners' return on equity of 1.04% beat Charming Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Charming MedicalN/A N/A N/A
Surgery Partners -2.28%1.04%0.41%

Charming Medical has higher earnings, but lower revenue than Surgery Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charming MedicalN/AN/AN/AN/AN/A
Surgery Partners$3.31B0.53-$77.90M-$0.60N/A

Surgery Partners has a consensus target price of $22.18, indicating a potential upside of 65.54%. Given Surgery Partners' stronger consensus rating and higher probable upside, analysts plainly believe Surgery Partners is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.58

In the previous week, Charming Medical had 2 more articles in the media than Surgery Partners. MarketBeat recorded 3 mentions for Charming Medical and 1 mentions for Surgery Partners. Charming Medical's average media sentiment score of 0.11 beat Surgery Partners' score of 0.00 indicating that Charming Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charming Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Surgery Partners
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Surgery Partners beats Charming Medical on 6 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Viridian Therapeutics?

Viridian Therapeutics (NASDAQ:VRDN) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

Charming Medical has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -490.31%. Charming Medical's return on equity of 0.00% beat Viridian Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Viridian Therapeutics-490.31% -80.19% -48.84%
Charming Medical N/A N/A N/A

Viridian Therapeutics currently has a consensus price target of $36.14, suggesting a potential upside of 109.65%. Given Viridian Therapeutics' stronger consensus rating and higher possible upside, equities analysts plainly believe Viridian Therapeutics is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viridian Therapeutics
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.79
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Charming Medical has lower revenue, but higher earnings than Viridian Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viridian Therapeutics$70.85M25.08-$342.60M-$3.32N/A
Charming MedicalN/AN/AN/AN/AN/A

In the previous week, Viridian Therapeutics had 1 more articles in the media than Charming Medical. MarketBeat recorded 4 mentions for Viridian Therapeutics and 3 mentions for Charming Medical. Charming Medical's average media sentiment score of 0.11 beat Viridian Therapeutics' score of 0.00 indicating that Charming Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Viridian Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Charming Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Viridian Therapeutics beats Charming Medical on 5 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Progyny?

Charming Medical (NASDAQ:MCTA) and Progyny (NASDAQ:PGNY) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

In the previous week, Progyny had 6 more articles in the media than Charming Medical. MarketBeat recorded 9 mentions for Progyny and 3 mentions for Charming Medical. Progyny's average media sentiment score of 0.33 beat Charming Medical's score of 0.11 indicating that Progyny is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charming Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Progyny
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

94.9% of Progyny shares are owned by institutional investors. 9.9% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Progyny has higher revenue and earnings than Charming Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charming MedicalN/AN/AN/AN/AN/A
Progyny$1.29B1.51$58.52M$0.7732.31

Progyny has a net margin of 5.23% compared to Charming Medical's net margin of 0.00%. Progyny's return on equity of 13.34% beat Charming Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Charming MedicalN/A N/A N/A
Progyny 5.23%13.34%9.03%

Progyny has a consensus target price of $29.55, suggesting a potential upside of 18.75%. Given Progyny's stronger consensus rating and higher probable upside, analysts plainly believe Progyny is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Progyny
0 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.92

Summary

Progyny beats Charming Medical on 12 of the 12 factors compared between the two stocks.

How does Charming Medical compare to Sonida Senior Living?

Sonida Senior Living (NYSE:SNDA) and Charming Medical (NASDAQ:MCTA) are both small-cap services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Sonida Senior Living presently has a consensus target price of $38.75, indicating a potential upside of 5.18%. Given Sonida Senior Living's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sonida Senior Living is more favorable than Charming Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonida Senior Living
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Charming Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Charming Medical has a net margin of 0.00% compared to Sonida Senior Living's net margin of -24.15%. Charming Medical's return on equity of 0.00% beat Sonida Senior Living's return on equity.

Company Net Margins Return on Equity Return on Assets
Sonida Senior Living-24.15% -36.98% -7.08%
Charming Medical N/A N/A N/A

87.6% of Sonida Senior Living shares are owned by institutional investors. 3.1% of Sonida Senior Living shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Charming Medical has lower revenue, but higher earnings than Sonida Senior Living.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sonida Senior Living$381.14M4.58-$70.78M-$5.83N/A
Charming MedicalN/AN/AN/AN/AN/A

In the previous week, Charming Medical had 2 more articles in the media than Sonida Senior Living. MarketBeat recorded 3 mentions for Charming Medical and 1 mentions for Sonida Senior Living. Sonida Senior Living's average media sentiment score of 0.88 beat Charming Medical's score of 0.11 indicating that Sonida Senior Living is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sonida Senior Living
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Charming Medical
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Sonida Senior Living beats Charming Medical on 7 of the 11 factors compared between the two stocks.

Get Charming Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCTA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCTA vs. The Competition

Export
MetricCharming MedicalServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$497.21M$1.46B$965.46M$12.31B
Dividend YieldN/AN/A5.15%5.32%
P/E RatioN/A13.099.1225.65
Price / SalesN/A6.6736.6187.36
Price / CashN/A3,219.57391.8256.72
Price / BookN/A4.444.357.12
Net IncomeN/A-$26.94M-$6.42M$335.28M
7 Day PerformanceN/A1.19%-2.03%2.66%
1 Month PerformanceN/A-4.52%-6.74%1.39%
1 Year PerformanceN/AN/A44.89%35.43%

Charming Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCTA
Charming Medical
N/A$29.36
+6.8%		N/AN/A$497.21MN/AN/A49
ADUS
Addus HomeCare
4.6413 of 5 stars		$98.49
+0.7%		$132.33
+34.4%		-15.3%$1.83B$1.42B18.2150,659
SGRY
Surgery Partners
3.1483 of 5 stars		$13.97
+1.4%		$22.18
+58.8%		-41.4%$1.80B$3.31BN/A16,000
VRDN
Viridian Therapeutics
3.4721 of 5 stars		$16.86
-2.0%		$37.31
+121.3%		+29.5%$1.77B$70.85MN/A50
PGNY
Progyny
4.0205 of 5 stars		$23.45
+4.0%		$28.18
+20.2%		+16.5%$1.77B$1.29B30.45310

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MCTA) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners
Your computer is about to become a museum piece
Vanguard holds $101 billion in three AI companies most investors have never heard of. BlackRock holds $82 bill...
Eagle Publishing | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Revealed: The Best Kept Secrets On Wall Street
Tom Busby, founder of the Diversified Trading Institute, is giving away his 'Little Black Book' - a collection...
DTI Trader | Sponsoredtc pixel
One algorithm, 17 years, nearly 2,000% total returns
A physicist in Dublin claims his AI algorithm has beaten the market for 17 consecutive years - with nearly 2,0...
Porter & Company | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel